Industry Verticals »

All Categories

Insights »

About TMR »

Breast Reconstruction Market

Breast Reconstruction Market (Product: Breast Implants, Tissue Expanders, Acellular Dermal Matrix, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Breast Reconstruction Market Outlook 2031

  • The global breast reconstruction market was valued at US$ 1.4 Bn in 2021
  • The global market is projected to grow at a CAGR of 5.3% from 2022 to 2031
  • The global breast reconstruction market is anticipated to reach more than US$ 2.5 Bn by 2031

Analysts’ Viewpoint on Breast Reconstruction Market Scenario

Ongoing advancements in breast reconstruction procedures that focus on improving accuracy in implant positioning, and reducing operative time and pain are driving the global breast reconstruction market. Incorporation of innovative technologies in combination with ADMs (acellular dermal matrix), such as the shift from two-step breast reconstruction procedure to a single step breast reconstruction procedure, is likely to increase the adoption of ADMs faster than that of breast implants in the next few years. The global breast reconstruction market is expected to be driven by the rise in prevalence of breast cancer across the world and increase in number of breast reconstruction procedures. Post the peak of the COVID-19 pandemic, companies in the breast reconstruction market are taking data-driven decisions before investing in new technologies. Market players should concentrate on investing in research and clinical trials to introduce safer and innovative solutions for their target customers.

breast reconstruction market

Overview of Global Breast Reconstruction Market

  • Rise in prevalence of breast cancer, increase in number of breast reconstruction procedures, and surge in demand for acellular dermal matrix are projected to drive the global breast reconstruction market. According to the World Health Organization (WHO), 2.3 million women were diagnosed with breast cancer, while 685,000 deaths were reported globally in 2020. Breast cancer is the leading cancer among females in India, with age adjusted rate as high as 25.8 per 100,000 women and mortality rate at 12.7 per 100,000. About one in eight women in the U.S. (around 13%) develops invasive breast cancer over the course of her lifetime.
  • The popularity of breast reconstruction after mastectomy is increasing across the globe. According to the American Society of Plastic Surgeons (ASPS), 78,832 breast reconstruction surgeries were performed in 2000. The number increased to 106,295 in 2017.
  • Acellular dermal matrix provides support to the breast implant. It exhibits positive outcomes, especially in patients with immediate reconstruction after mastectomy. Increase in demand for the matrix can be ascribed to the rise in number of surgeons using it for breast reconstruction and augmentation; and surge in awareness about advantages of acellular dermal matrices in breast reconstruction, abdominal wall reconstruction, nasal reconstruction, and eyelid reconstruction.
  • According to the American Society of Plastic Surgeons, the total number of breast reconstruction procedures using the acellular dermal matrix stood at 58,310 in the U.S. in 2016. It increased to 59,774 in 2017. Of the 101,657 breast reconstructions performed in the U.S. in 2018, 69,921 (69%) used tissue expanders and implants; and 61,713 (61%) used ADMs.

Impact of COVID-19 on Breast Reconstruction Market

Elective surgeries such as breast reconstruction were postponed in several countries during the peak of the COVID-19 pandemic. An article published in the Journal of Plastic, Reconstructive & Aesthetic Surgery in February 2022 stated that oncologic breast surgeries and reconstructive surgeries declined by 6.8% and 11%, respectively, in 2020 against that in 2019.

Increase in Demand for Silicone & Saline Breast Implants Boosting Breast Implants Segment

  • In terms of product, the breast implants segment accounted for more than 42% value share of the global market in 2021. This can be ascribed to the rise in number of breast cancer cases & breast reconstruction procedures and increase in demand for silicone & saline breast implants. Two types of breast implants are used for breast reconstruction & augmentation procedures: silicone and saline implants. Silicone implants accounted for the key share of the market in 2021, owing to the large number of silicone breast implantation procedures performed across the world.
  • The acellular dermal matrix (ADM) segment is projected to grow at a rapid pace during the forecast period, as ADM is increasingly used in implant-based breast reconstruction surgeries in order to correct breast deformities such as rippling and contracture

Growth in Breast Reconstruction Procedures in Hospitals to Drive Hospitals Segment

  • The hospitals segment held the largest share of the global market in 2021. This trend is anticipated to continue during the forecast period. Growth in number of breast reconstruction procedures performed in hospitals is augmenting the segment.
  • The ambulatory surgery centers segment is expected to grow at the fastest CAGR during the forecast period. Ambulatory surgery centers have the ability to improve quality and customer service, while simultaneously reducing costs. In the last few decades, the number of surgical procedures carried out on the same-day basis has increased significantly in countries in the West. More than two-thirds of operations performed in the U.S. are carried out in outpatient centers; a few of these are owned by hospitals.

Regional Outlook of Breast Reconstruction Market

  • North America accounted for significant share of the global breast reconstruction market in 2021. This trend is expected to continue during the forecast period. Growth of the market in the region can be ascribed to technological advancements in breast reconstruction devices, increase in number of players manufacturing breast implants & acellular dermal matrices, and steady rise in prevalence of breast cancer. According to data published by ISAPS, the total number of breast reconstruction procedures performed in the U.S. stood at 541,167 in 2019. It increased to 596,896 in 2020.
  • The market in Asia Pacific is likely to be driven by the increase in the number of players launching new products in countries such as Japan, China, India, and Australia; rise in prevalence of breast cancer; and high demand for breast implants. Surge in disposable income and increase in availability of surgical procedures in hospitals and ambulatory surgical centers are also projected to augment the breast construction market in the region.

Analysis of Key Players in Global Breast Reconstruction Market

The breast reconstruction market report includes vital information about the key players operating in the global market. Companies are focusing on strategies such as new product launches, mergers & acquisitions (M&A), and partnerships to strengthen their position in the market. AbbVie, Inc., Establishment Labs Holdings, Inc., GC Aesthetics, Groupe SEBBIN SAS, Guangzhou Wanhe Plastic Materials Co., Ltd., Integra LifeSciences, Mentor Worldwide LLC (Johnson & Johnson), POLYTECH Health & Aesthetics GmbH, RTI Surgical, Inc., and Sientra, Inc. are some of the prominent entities operating in this market.

Key Developments in Global Breast Reconstruction Market

  • In May 2021, GC Aesthetics launched PERLE, the next generation of breast implants, which is a novel round breast implant with (R)evolutionary BioQ–surface technology and highly cohesive Emunomic Breast Tissue Dynamic Gel in Europe
  • In March 2018, Establishment Labs Holdings, Inc. received the U.S. Food and Drug Administration approval for an investigational device exemption (IDE). In April 2018, the company initiated the Motiva Implant clinical trial in the U.S. This approval enabled the company to continue with its multi-center study investigating female patients receiving primary breast reconstruction, primary breast augmentation, or revision surgery. Establishment Labs Holdings, Inc. focuses on establishing its presence in the breast reconstruction market in the U.S.
  • In April 2018, RTI Surgical, Inc. launched its Fortiva Tissue Line in the international market. Fortiva Tissue Line was exclusively launched for breast reconstruction surgery. The move enabled the company to offer its innovative solutions to surgeons, hospitals, and patients.

Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Breast Reconstruction Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 1.4 Bn

Market Forecast Value in 2031

More than US$ 2.5 Bn

Compound Annual Growth Rate (CAGR)

5.3%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Mn for Value

Market Analysis

It includes segment and regional analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape
  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation
  • Product
    • Breast Implants
      • Silicone
      • Saline
    • Tissue Expanders
    • Acellular Dermal Matrix (ADM)
    • Others
  • End-user
    • Hospitals
    • Cosmetology Clinics
    • Ambulatory Surgery Centers

Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled
  • AbbVie, Inc.
  • Establishment Labs Holdings, Inc.
  • GC Aesthetics
  • Groupe SEBBIN SAS
  • Guangzhou Wanhe Plastic Materials Co., Ltd.
  • Integra LifeSciences
  • Mentor Worldwide LLC (Johnson & Johnson)
  • POLYTECH Health & Aesthetics GmbH
  • RTI Surgical, Inc.
  • Sientra, Inc.

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global breast reconstruction market in 2021?

The global breast reconstruction market was valued at US$ 1.4 Bn in 2021.

How big will be the global breast reconstruction market by 2031?

The global breast reconstruction market is projected to reach more than US$ 2.5 Bn by 2031.

What was the CAGR of the global breast reconstruction market from 2017 to 2021?

The global breast reconstruction market expanded at a CAGR of 2.2% from 2017 to 2021.

What will be the CAGR of the global breast reconstruction market during the forecast period (2022–2031)?

The global breast reconstruction market is anticipated to grow at a CAGR of 5.3% from 2022 to 2031.

Which are the prominent trends that affect market growth?

Rise in prevalence of breast cancer and increase in number of breast reconstruction procedures are the major factors driving the global breast reconstruction market.

What was the market share of the leading segment of the global breast reconstruction market?

The breast implants segment accounted for more than 42% share of the global breast reconstruction market in 2021.

Which region will account for major share of the global market during the forecast period?

North America is expected to account for major share of the global market during the forecast period.

Who are the prominent players in the global breast reconstruction market?

AbbVie, Inc., Establishment Labs Holdings, Inc., GC Aesthetics, Groupe SEBBIN SAS, Guangzhou Wanhe Plastic Materials Co., Ltd., Integra LifeSciences, Mentor Worldwide LLC (Johnson & Johnson), POLYTECH Health & Aesthetics GmbH, RTI Surgical, Inc., and Sientra, Inc. are the prominent players operating in the global breast reconstruction market.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Breast Reconstruction Market

4. Market Overview

    4.1. Overview

    4.2. Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Opportunities

5. Key Insights

    5.1. New Product Launches and Regulatory Approvals

    5.2. Technological Advancements

    5.3. COVID-19 Pandemic Impact

6. Global Breast Reconstruction Market Analysis and Forecast, By Product

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product, 2017–2031

        6.3.1. Breast Implants

            6.3.1.1. Silicone

            6.3.1.2. Saline

        6.3.2. Tissue Expanders

        6.3.3. Acellular Dermal Matrix (ADM)

        6.3.4. Others

    6.4. Market Attractiveness Analysis, By Product

7. Global Breast Reconstruction Market Analysis and Forecast, By End-user

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by End-user, 2017–2031

        7.3.1. Hospitals

        7.3.2. Cosmetology Clinics

        7.3.3. Ambulatory Surgery Centers

    7.4. Market Attractiveness Analysis, By End-user

8. Global Breast Reconstruction Market Analysis and Forecast, By Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness Analysis, By Region

9. North America Breast Reconstruction Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Product, 2017–2031

        9.2.1. Breast Implants

            9.2.1.1. Silicone

            9.2.1.2. Saline

        9.2.2. Tissue Expanders

        9.2.3. Acellular Dermal Matrix (ADM)

        9.2.4. Others

    9.3. Market Value Forecast, by End-user, 2017–2031

        9.3.1. Hospitals

        9.3.2. Cosmetology Clinics

        9.3.3. Ambulatory Surgery Centers

    9.4. Market Value Forecast, by Country, 2017–2031

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis

        9.5.1. By Product

        9.5.2. By End-user

        9.5.3. By Country

10. Europe Breast Reconstruction Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product, 2017–2031

        10.2.1. Breast Implants

            10.2.1.1. Silicone

            10.2.1.2. Saline

        10.2.2. Tissue Expanders

        10.2.3. Acellular Dermal Matrix (ADM)

        10.2.4. Others

    10.3. Market Value Forecast, by End-user, 2017–2031

        10.3.1. Hospitals

        10.3.2. Cosmetology Clinics

        10.3.3. Ambulatory Surgery Centers

    10.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Italy

        10.4.5. Spain

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis

        10.5.1. By Product

        10.5.2. By End-user

        10.5.3. By Country/Sub-region

11. Asia Pacific Breast Reconstruction Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product, 2017–2031

        11.2.1. Breast Implants

            11.2.1.1. Silicone

            11.2.1.2. Saline

        11.2.2. Tissue Expanders

        11.2.3. Acellular Dermal Matrix (ADM)

        11.2.4. Others

    11.3. Market Value Forecast, by End-user, 2017–2031

        11.3.1. Hospitals

        11.3.2. Cosmetology Clinics

        11.3.3. Ambulatory Surgery Centers

    11.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.4.1. Japan

        11.4.2. China

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis

        11.5.1. By Product

        11.5.2. By End-user

        11.5.3. By Country/Sub-region

12. Latin America Breast Reconstruction Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product, 2017–2031

        12.2.1. Breast Implants

            12.2.1.1. Silicone

            12.2.1.2. Saline

        12.2.2. Tissue Expanders

        12.2.3. Acellular Dermal Matrix (ADM)

        12.2.4. Others

    12.3. Market Value Forecast, by End-user, 2017–2031

        12.3.1. Hospitals

        12.3.2. Cosmetology Clinics

        12.3.3. Ambulatory Surgery Centers

    12.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Market Attractiveness Analysis

        12.5.1. By Product

        12.5.2. By End-user

        12.5.3. By Country/Sub-region

13. Middle East & Africa Breast Reconstruction Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product, 2017–2031

        13.2.1. Breast Implants

            13.2.1.1. Silicone

            13.2.1.2. Saline

        13.2.2. Tissue Expanders

        13.2.3. Acellular Dermal Matrix (ADM)

        13.2.4. Others

    13.3. Market Value Forecast, by End-user, 2017–2031

        13.3.1. Hospitals

        13.3.2. Cosmetology Clinics

        13.3.3. Ambulatory Surgery Centers

    13.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Market Attractiveness Analysis

        13.5.1. By Product

        13.5.2. By End-user

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (by tier and size of companies)

    14.2. Market Share Analysis/Ranking, by Company, 2021

    14.3. Company Profiles

        14.3.1. AbbVie, Inc.

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Product Portfolio

            14.3.1.3. Financial Overview

            14.3.1.4. SWOT Analysis

            14.3.1.5. Strategic Overview

        14.3.2. Establishment Labs Holdings, Inc.

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Product Portfolio

            14.3.2.3. Financial Overview

            14.3.2.4. SWOT Analysis

            14.3.2.5. Strategic Overview

        14.3.3. GC Aesthetics

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Product Portfolio

            14.3.3.3. Financial Overview

            14.3.3.4. SWOT Analysis

            14.3.3.5. Strategic Overview

        14.3.4. Groupe SEBBIN SAS

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Product Portfolio

            14.3.4.3. Financial Overview

            14.3.4.4. SWOT Analysis

            14.3.4.5. Strategic Overview

        14.3.5. Guangzhou Wanhe Plastic Materials Co., Ltd.

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Product Portfolio

            14.3.5.3. Financial Overview

            14.3.5.4. SWOT Analysis

            14.3.5.5. Strategic Overview

        14.3.6. Integra LifeSciences

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Product Portfolio

            14.3.6.3. Financial Overview

            14.3.6.4. SWOT Analysis

            14.3.6.5. Strategic Overview

        14.3.7. Mentor Worldwide LLC (Johnson & Johnson)

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Product Portfolio

            14.3.7.3. Financial Overview

            14.3.7.4. SWOT Analysis

            14.3.7.5. Strategic Overview

        14.3.8. POLYTECH Health & Aesthetics GmbH

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.8.2. Product Portfolio

            14.3.8.3. Financial Overview

            14.3.8.4. SWOT Analysis

            14.3.8.5. Strategic Overview

        14.3.9. RTI Surgical, Inc.

            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.9.2. Product Portfolio

            14.3.9.3. Financial Overview

            14.3.9.4. SWOT Analysis

            14.3.9.5. Strategic Overview

        14.3.10. Sientra, Inc.

            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.10.2. Product Portfolio

            14.3.10.3. Financial Overview

            14.3.10.4. SWOT Analysis

            14.3.10.5. Strategic Overview

        14.3.11. Other prominent players

List of Tables

Table 01: New Product Launches and Regulatory Approvals in Breast Reconstruction Market, by Company

Table 02: New Product Launches and Regulatory Approvals in Breast Reconstruction Market, by Company

Table 03: Global Breast Reconstruction Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 04: Global Breast Reconstruction Market Value (US$ Mn) Forecast, by Breast Implants, 2017–2031

Table 05: Global Breast Reconstruction Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 06: Global Breast Reconstruction Market Size (US$ Mn) Forecast, by Region, 2017–2031

Table 07: North America Breast Reconstruction Market Size (US$ Mn) Forecast, by Country, 2017–2031

Table 08: North America Breast Reconstruction Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 09: North America Breast Reconstruction Market Size (US$ Mn) Forecast, by Breast Implants, 2017–2031

Table 10: North America Breast Reconstruction Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 11: Europe Breast Reconstruction Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 12: Europe Breast Reconstruction Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 13: Europe Breast Reconstruction Market Size (US$ Mn) Forecast, by Breast Implants, 2017–2031

Table 14: Europe Breast Reconstruction Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 15: Asia Pacific Breast Reconstruction Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 16: Asia Pacific Breast Reconstruction Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 17: Asia Pacific Breast Reconstruction Market Size (US$ Mn) Forecast, by Breast Implants, 2017–2031

Table 18: Asia Pacific Breast Reconstruction Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 19: Latin America Breast Reconstruction Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 20: Latin America Breast Reconstruction Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 21: Latin America Breast Reconstruction Market Size (US$ Mn) Forecast, by Breast Implants, 2017–2031

Table 22: Latin America Breast Reconstruction Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 23: Middle East & Africa Breast Reconstruction Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 24: Middle East & Africa Breast Reconstruction Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 25: Middle East & Africa Breast Reconstruction Market Size (US$ Mn) Forecast, by Breast Implants, 2017–2031

Table 26: Middle East & Africa Breast Reconstruction Market Size (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Breast Reconstruction Market Size (US$ Mn) and Distribution (%), by Region, 2021 and 2031

Figure 02: Global Breast Reconstruction Market Value Share, by Product, 2021

Figure 03: Global Breast Reconstruction Market Value Share, by End-user, 2021

Figure 04: Global Breast Reconstruction Market Value Share, by Region, 2021

Figure 05: Global Breast Reconstruction Market, By Region (US$ Mn), 2021

Figure 06: Global Breast Reconstruction Market Value (US$ Mn) Forecast, 2017–2031

Figure 07: Global Breast Reconstruction Market Value Share Analysis, by Product, 2021 and 2031

Figure 08: Global Breast Reconstruction Market Revenue (US$ Mn), by Breast Implants, 2017–2031

Figure 09: Global Breast Reconstruction Market Revenue (US$ Mn), by Tissue Expanders, 2017–2031

Figure 10: Global Breast Reconstruction Market Revenue (US$ Mn), by Acellular Dermal Matrix (ADM), 2017–2031

Figure 11: Global Breast Reconstruction Market Revenue (US$ Mn), by Others, 2017–2031

Figure 12: Global Breast Reconstruction Market Attractiveness Analysis, by Product, 2022–2031

Figure 13: Global Breast Reconstruction Market Value Share Analysis, by End-user, 2021 and 2031

Figure 14: Global Breast Reconstruction Market Revenue (US$ Mn), by Hospitals, 2017–2031

Figure 15: Global Breast Reconstruction Market Revenue (US$ Mn), by Cosmetology Clinics, 2017–2031

Figure 16: Global Breast Reconstruction Market Revenue (US$ Mn), by Ambulatory Surgery Centers, 2017–2031

Figure 17: Global Breast Reconstruction Market Attractiveness Analysis, by End-user, 2022–2031

Figure 18: Global Breast Reconstruction Market Value Share Analysis, by Region, 2021 and 2031

Figure 19: Global Breast Reconstruction Market Attractiveness Analysis, by Region, 2022–2031

Figure 20: North America Breast Reconstruction Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 21: North America Breast Reconstruction Market Attractiveness Analysis, by Country, 2022–2031

Figure 22: North America Breast Reconstruction Market Value Share Analysis, by Country, 2021 and 2031

Figure 23: North America Breast Reconstruction Market Value Share Analysis, by Product, 2021 and 2031

Figure 24: North America Breast Reconstruction Market Value Share Analysis, by End-user, 2021 and 2031

Figure 25 North America Breast Reconstruction Market Attractiveness Analysis, by Product, 2022–2031

Figure 26: North America Breast Reconstruction Market Attractiveness Analysis, by End-user, 2022–2031

Figure 27: Europe Breast Reconstruction Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 28: Europe Breast Reconstruction Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 29: Europe Breast Reconstruction Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 30: Europe Breast Reconstruction Market Value Share Analysis, by Product, 2021 and 2031

Figure 31: Europe Breast Reconstruction Market Value Share Analysis, by End-user, 2021 and 2031

Figure 32: Europe Breast Reconstruction Market Attractiveness Analysis, by Product, 2022–2031

Figure 33: Europe Breast Reconstruction Market Attractiveness Analysis, by End-user, 2022–2031

Figure 34: Asia Pacific Breast Reconstruction Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 35: Asia Pacific Breast Reconstruction Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 36: Asia Pacific Breast Reconstruction Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 37: Asia Pacific Breast Reconstruction Market Value Share Analysis, by Product, 2021 and 2031

Figure 38: Asia Pacific Breast Reconstruction Market Value Share Analysis, by End-user, 2021 and 2031

Figure 39: Asia Pacific Breast Reconstruction Market Attractiveness Analysis, by Product, 2022–2031

Figure 40: Asia Pacific Breast Reconstruction Market Attractiveness Analysis, by End-user, 2022–2031

Figure 41: Latin America Breast Reconstruction Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 42: Latin America Breast Reconstruction Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 43: Latin America Breast Reconstruction Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 44: Latin America Breast Reconstruction Market Value Share Analysis, by Product, 2021 and 2031

Figure 45: Latin America Breast Reconstruction Market Value Share Analysis, by End-user, 2021 and 2031

Figure 46: Latin America Breast Reconstruction Market Attractiveness Analysis, by Product, 2022–2031

Figure 47: Latin America Breast Reconstruction Market Attractiveness Analysis, by End-user, 2022–2031

Figure 48: Middle East & Africa Breast Reconstruction Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 49: Middle East & Africa Breast Reconstruction Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 50: Middle East & Africa Breast Reconstruction Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 51: Middle East & Africa Breast Reconstruction Market Value Share Analysis, by Product, 2021 and 2031

Figure 52: Middle East & Africa Breast Reconstruction Market Value Share Analysis, by End-user, 2021 and 2031

Figure 53: Middle East & Africa Breast Reconstruction Market Attractiveness Analysis, by Product, 2022–2031

Figure 54: Middle East & Africa Breast Reconstruction Market Attractiveness Analysis, by End-user, 2022–2031

Figure 55: Market Share Analysis/Ranking, by Company, 2021

Copyright © Transparency Market Research, Inc. All Rights reserved

Breast Reconstruction Market

Schedule a Call